AIFAS was founded with the vision to create a leading independent M&A advisory firm in Japan.


Independent M&A Advisory Firm in Japan

  • AIFAS advises clients on strategic transactions with a primary focus in the healthcare and consumer goods industries. We provide solutions tailored to meet individual client needs.
  • We are a one-stop shop for our clients across the globe, offering comprehensive financial advisory services, including pre-deal consultation and origination, transaction planning, execution and post-merger integration.
  • Our advisory expertise extends across the full range of strategic transactions, including M&A, business integration, licensing and medium- to large-scale cross-border transactions.
  • As an independent advisory firm, we are committed to placing our clients’ interests first. We are free of the conflicts of interest that arise at traditional investment banks.

Healthcare Focus

  • Our client base includes companies across the healthcare value chain, including large-cap pharmaceuticals (i.e., new and generic drug manufacturers), biotechnology, outsourcing (e.g., CROs, CDMOs), distribution (e.g., wholesalers, retailers) and medical devices. We have ongoing strategic dialogues with the executive level management and key decision makers at these companies.
  • Our experience across various sectors in the healthcare industry has equipped us with an unparalleled edge in advising our healthcare clients. AIFAS’s track record also includes working with bio-ventures and financial investors in the healthcare industry.
  • Leveraging our domestic and international network of major and niche market players, key opinion leaders, decision makers and coverage bankers, we are well positioned to provide in-depth industry insight, and to conceive and execute transactions in the healthcare industry, in other market sectors (e.g., consumer goods), and across several geographic regions.
  • Our resources are largely devoted to healthcare industry transactions. As such, we are among only a handful of M&A advisory firms in Japan with primary expertise in the healthcare industry.


  • The majority of our transactions involve a cross-border element, including acquisitions, sales, investments, joint-ventures, licensing and consulting for domestic and foreign clients. In conjunction with our local transactional expertise, we apply a global-minded approach.
  • Our experience includes deal origination and execution involving the United States, Europe (e.g., U.K., Germany, France, Spain, Switzerland), the Middle East (e.g., Israel) and Asia (e.g., India, China, Vietnam).

Based on our market coverage and insight, we specialize in supporting both foreign businesses with their entry into the Japanese market and domestic businesses with their global-expansion initiatives

Long-Term Commitment

  • We provide strategic advice from a global and independent point of view, as a means for our clients to achieve their mid- to long-term strategic goals.
  • We measure our success in parallel with our clients’ satisfaction, and are dedicated to creating value for our clients’ businesses.
  • Our clients are our first priority. We strive to develop trust and are committed to building long-term client relationships.